FANGZHOU JIANKE(06086.HK)

Last Updated 08:00:00
longbridge loading
Company Encyclopedia
View More
name
FANGZHOU JIANKE
06086.HK
Fangzhou Inc. provides online chronic disease management services in China. It operates through four segments: Online Retail Pharmacy Services; Comprehensive Medical Services; Wholesale; and Customized Content And Marketing Solutions. The company offers services through online chronic disease management platform to address the needs of patients with chronic disease, such as hypertension, cardiovascular and respiratory chronic diseases.
221.53 B
06086.HKMarket value -Rank by Market Cap -/-

Financial Score

19/05/2026 Update
B
Drug RetailIndustry
Industry Ranking5/7
Industry medianB
Industry averageB
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE8.29%B
    • Profit Margin0.34%C
    • Gross Margin15.87%D
  • Growth ScoreA
    • Revenue YoY31.50%A
    • Net Profit YoY101.40%A
    • Total Assets YoY28.11%A
    • Net Assets YoY22.01%A
  • Cash ScoreA
    • Cash Flow Margin615.71%A
    • OCF YoY31.50%A
  • Operating ScoreA
    • Turnover4.77A
  • Debt ScoreE
    • Gearing Ratio81.11%E

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    AI Healthcare Stocks Surge in Hong Kong Market

    CoinLive·
    HK
    02661
    -1.41%
    SH
    513120
    +0.18%
    SH
    512010
    0.00%
    CoinLive·
    HK
    02661
    -1.41%
    SH
    513120
    +0.18%
    SH
    512010
    0.00%

    Citi lowers the target price for FANGZHOU JIANKE to 7.5 yuan, stating that its value is severely underestimated

    AASTOCKS·
    HK
    06086
    -0.98%
    SH
    513120
    +0.18%
    AASTOCKS·
    HK
    06086
    -0.98%
    SH
    513120
    +0.18%

    "Performance" FANGZHOU JIANKE achieved a net profit of 10.86 million RMB for the year, turning a loss into a profit

    AASTOCKS·
    HK
    06086
    -0.98%
    AASTOCKS·
    HK
    06086
    -0.98%

    Fangzhou Swings to Profit as Revenue Surges and Digital Health Platform Expands

    Tip Ranks·
    HK
    06086
    -0.98%
    HK
    00700
    +2.40%
    US
    TCEHY
    +2.04%
    Tip Ranks·
    HK
    06086
    -0.98%
    HK
    00700
    +2.40%
    US
    TCEHY
    +2.04%

    Fangzhou, Youcare Partner To Advance AI In Chronic Disease Care

    rttnews·
    HK
    06086
    -0.98%
    SH
    510660
    +0.09%
    SH
    512010
    0.00%
    rttnews·
    HK
    06086
    -0.98%
    SH
    510660
    +0.09%
    SH
    512010
    0.00%
    © 2026 Longbridge｜Disclaimer